SNDL Announces Successful Completion of EU-GMP Audit at Atholville Facility
SNDL announced the successful completion of an EU-GMP audit at its Atholville, New Brunswick cultivation facility. The company said the result reinforces its ability to participate in regulated international medical cannabis markets and reflects its focus on quality, operational excellence, and regulatory compliance.
Why it matters — A successful audit supports SNDL's standing in regulated international medical cannabis markets, so a watcher would care about the compliance milestone at one of its cultivation facilities.